CSU is a severe form of hives that ... before planning its next steps. Dupixent is already approved to treat a range of inflammatory diseases including atopic dermatitis, asthma, and chronic ...

IL-4 and IL-13 inhibitor Dupixent ... form of inflammation – and Sanofi is hoping amlitelimab could be suitable for broader use. The drug has also shown efficacy in a phase 2b atopic dermatitis ...